Home Online Features Protega Pharmaceuticals Receives FDA Approval for ROXYBOND™ (oxycodone hydrochloride) Immediate-Release 10 mg Tablet with Abuse-Deterrent Technology for Management of Pain
Protega Pharmaceuticals Receives FDA Approval for ROXYBOND™ (oxycodone hydrochloride) Immediate-Release 10 mg Tablet with Abuse-Deterrent Technology for Management of Pain
Hand-out
Press Releases
Protega  
October 29, 2024

Protega Pharmaceuticals Receives FDA Approval for ROXYBOND™ (oxycodone hydrochloride) Immediate-Release 10 mg Tablet with Abuse-Deterrent Technology for Management of Pain

Patented SentryBond™ technology, a first-of-its-kind abuse-deterrent technology, is designed to provide multiple levels of protection and has the potential to be utilized in other medications

avatar profile Olean Times Herald

Olean Times Herald

email Olean Times Herald

Local & Social